fda semaglutide shortage resolved february 21 2025 Ozempic, Wegovy Is Officially Over 🚨 FDA Moves to Permanently

Several large studies using electronic health records and insurance claims data have tracked people using GLP-1 medications for five years or more

GLP1-RA reduced the risk of the broad composite kidney outcome significantly by 17% which was only driven by a reduction in macroalbuminuria (26% reduction)

Do not assume your window has closed without speaking to an attorney first

Safety Considerations Knowing how long GLP-1 stays in your system is also important for safety

Directing GLP-1 prescriptions through specific vendors or specialty pharmacies can improve pricing transparency and rebate capture

Heymsfield SB, Coleman LA, Miller R, et al